{"id":536481,"date":"2021-09-09T09:28:15","date_gmt":"2021-09-09T13:28:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/"},"modified":"2021-09-09T09:28:15","modified_gmt":"2021-09-09T13:28:15","slug":"novavax-to-participate-in-upcoming-september-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/","title":{"rendered":"Novavax to Participate in Upcoming September Conferences"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n GAITHERSBURG, Md.<\/span>, Sept. 9, 2021<\/span> \/PRNewswire\/ —\u00a0Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in two upcoming investor conferences. Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion.<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\n
\n H.C. Wainwright 23rd<\/sup> Annual Global Investment Conference (Virtual)<\/b>
\n <\/span>\n <\/p>\n

\n
\n Fireside Chat<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Date:<\/span>\n <\/p>\n<\/td>\n

\n

\n Monday, September 13, 2021<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Time:<\/span>\n <\/p>\n<\/td>\n

\n

\n Available on-demand starting at 7:00 a.m. Eastern Time (ET)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Moderator:<\/span>\n <\/p>\n<\/td>\n

\n

\n Vernon Bernardino<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Novavax participants:<\/span>\n <\/p>\n<\/td>\n

\n

\n Gregory M. Glenn, M.D., President, Research and Development and John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n Panel<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Date:<\/span>\n <\/p>\n<\/td>\n

\n

\n Wednesday, September 15, 2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Time:<\/span>\n <\/p>\n<\/td>\n

\n

\n Available on-demand starting at 12:00 p.m. Eastern Time (ET)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Panel Title:<\/span>\n <\/p>\n<\/td>\n

\n

\n Best Practices \u2013 Planning for the Next Pandemic<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Moderator:<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Scott Gottlieb, M.D., Physician; Former Commissioner FDA<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Panelist: <\/span>\n <\/p>\n<\/td>\n

\n

\n John J. Trizzino, Executive Vice President, Chief Commercial <\/span>
\n Officer and Chief Business Officer<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n
\n\n\n\n\n\n\n\n
\n

\n
\n Morgan Stanley 19th<\/sup> Annual Global Healthcare Conference (Virtual)<\/b>
\n <\/span>\n <\/p>\n

\n
\n Fireside Chat<\/i>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Date:<\/span>\n <\/p>\n<\/td>\n

\n

\n Friday, September 10, 2021<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Time:<\/span>\n <\/p>\n<\/td>\n

\n

\n 2:00 \u2013 2:30 p.m. Eastern Time (ET)<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Moderator:<\/span>\n <\/p>\n<\/td>\n

\n

\n Jeffrey Hung<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n

\n Novavax participants:<\/span>\n <\/p>\n<\/td>\n

\n

\n Gregory M. Glenn, M.D., President, Research and Development and John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer<\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n<\/table><\/div>\n

\n Recordings
<\/b>All replays of the recorded fireside sessions will be available through the\u00a0events<\/a>\u00a0page of the Company’s website at\u00a0ir.novavax.com<\/a>\u00a0for 90 days from the date of the conference.<\/p>\n

\n About Novavax
<\/b>Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company’s proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. Novavax is conducting late-stage clinical trials for NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. NanoFlu\u2122, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults and will be advanced for regulatory submission. Both vaccine candidates incorporate Novavax’ proprietary saponin-based Matrix-M\u2122 adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies.<\/p>\n

For more information, visit www.novavax.com<\/a> and connect with us on Twitter<\/a> and LinkedIn<\/a>.<\/p>\n

\n Contacts:\u00a0<\/b>\u00a0\u00a0\u00a0\u00a0
Investors
<\/u>Novavax, Inc.
Erika Schultz<\/span> | 240-268-2022
ir@novavax.com<\/a><\/p>\n

Solebury Trout
Alexandra Roy\u00a0| 617-221-9197
aroy@soleburytrout.com<\/a><\/p>\n

\n Media
<\/u>
\n Alison Chartan<\/span> | 240-720-7804
Laura Keenan<\/span> | 202-709-7521
media@novavax.com<\/a><\/p>\n

\u00a0<\/p>\n

\n

\n
\n \"Novavax
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/novavax-to-participate-in-upcoming-september-conferences-301372455.html<\/a><\/p>\n

SOURCE Novavax, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire GAITHERSBURG, Md., Sept. 9, 2021 \/PRNewswire\/ —\u00a0Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in two upcoming investor conferences. Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion. H.C. Wainwright 23rd Annual Global Investment Conference (Virtual) Fireside Chat Date: Monday, September 13, 2021 Time: Available on-demand starting at 7:00 a.m. Eastern Time (ET) Moderator: Vernon Bernardino Novavax participants: Gregory M. Glenn, M.D., President, Research and Development and John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer Panel Date: Wednesday, September 15, 2021 Time: Available on-demand starting at 12:00 p.m. Eastern Time (ET) Panel Title: Best Practices \u2013 … <\/p>\n

Continue reading “Novavax to Participate in Upcoming September Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-536481","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNovavax to Participate in Upcoming September Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novavax to Participate in Upcoming September Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire GAITHERSBURG, Md., Sept. 9, 2021 \/PRNewswire\/ —\u00a0Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in two upcoming investor conferences. Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion. H.C. Wainwright 23rd Annual Global Investment Conference (Virtual) Fireside Chat Date: Monday, September 13, 2021 Time: Available on-demand starting at 7:00 a.m. Eastern Time (ET) Moderator: Vernon Bernardino Novavax participants: Gregory M. Glenn, M.D., President, Research and Development and John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer Panel Date: Wednesday, September 15, 2021 Time: Available on-demand starting at 12:00 p.m. Eastern Time (ET) Panel Title: Best Practices \u2013 … Continue reading "Novavax to Participate in Upcoming September Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-09T13:28:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1506866\/Novavax_High_Res_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Novavax to Participate in Upcoming September Conferences\",\"datePublished\":\"2021-09-09T13:28:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/\"},\"wordCount\":412,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1506866\\\/Novavax_High_Res_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/\",\"name\":\"Novavax to Participate in Upcoming September Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1506866\\\/Novavax_High_Res_Logo.jpg\",\"datePublished\":\"2021-09-09T13:28:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1506866\\\/Novavax_High_Res_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1506866\\\/Novavax_High_Res_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-participate-in-upcoming-september-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novavax to Participate in Upcoming September Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novavax to Participate in Upcoming September Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Novavax to Participate in Upcoming September Conferences - Market Newsdesk","og_description":"PR Newswire GAITHERSBURG, Md., Sept. 9, 2021 \/PRNewswire\/ —\u00a0Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in two upcoming investor conferences. Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion. H.C. Wainwright 23rd Annual Global Investment Conference (Virtual) Fireside Chat Date: Monday, September 13, 2021 Time: Available on-demand starting at 7:00 a.m. Eastern Time (ET) Moderator: Vernon Bernardino Novavax participants: Gregory M. Glenn, M.D., President, Research and Development and John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer Panel Date: Wednesday, September 15, 2021 Time: Available on-demand starting at 12:00 p.m. Eastern Time (ET) Panel Title: Best Practices \u2013 … Continue reading \"Novavax to Participate in Upcoming September Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-09T13:28:15+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1506866\/Novavax_High_Res_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Novavax to Participate in Upcoming September Conferences","datePublished":"2021-09-09T13:28:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/"},"wordCount":412,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1506866\/Novavax_High_Res_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/","name":"Novavax to Participate in Upcoming September Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1506866\/Novavax_High_Res_Logo.jpg","datePublished":"2021-09-09T13:28:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1506866\/Novavax_High_Res_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1506866\/Novavax_High_Res_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-participate-in-upcoming-september-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Novavax to Participate in Upcoming September Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=536481"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536481\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=536481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=536481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=536481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}